Biotech Values

[y3maxx]

"I'm willing to believe ItalFarmaco has a role as a manufacturer. But I'm a lot less willing to believe that T-enox is Lupenox. Maybe some day we'll know for sure."

Makes sense RockRat....hence MNTA's lawsuit thru discovery

2/
Dew et al, Might SNY consider straight generic pricing for potential competitive purposes?

One competitor being better than two or three.

If so, would it make Teva's potential T enox unprofitable and unappetizing?

"The enemy of my enemy is my friend"

3/
genisi
Teva's actions since July are all about protecting Copax to every degree...care to deny this fact?

4/
Currently TEVA is trading down @$1 Billion while MNTA is up @$250K.

tia

y3